Table 2. Grade 3 and 4 adverse events in the gemcitabine group (n=57).
Gemcitabine
|
||||
---|---|---|---|---|
Grade 3
a
|
Grade 4
a
|
|||
Adverse event | No. | % | No. | % |
Heamatological | ||||
Leukopenia | 13 | 23 | 1 | 2 |
Neutropenia | 32 | 56 | 8 | 14 |
Anaemia | 2 | 4 | 0 | 0 |
Thrombocytopenia | 1 | 2 | 0 | 0 |
Non-heamatological | ||||
Diarrhoea | 1 | 2 | 0 | 0 |
Fever | 1 | 2 | 0 | 0 |
Nausea | 0 | 0 | 1 | 2 |
Anorexia | 1 | 2 | 1 | 2 |
Fatigue | 1 | 2 | 0 | 0 |
AST | 3 | 5 | 0 | 0 |
ALT | 4 | 7 | 0 | 0 |
Abscess | 0 | 0 | 1 | 2 |
Abbreviations: ALT=alanine aminotransferase; AST=aspartate aminotransferase.
NCI Common Toxicity Criteria, version 2.0.